Overview

Phase I Pharmacokinetic Study of RX0041-2

Status:
Completed

Trial end date:
2015-10-01

Target enrollment:

Participant gender:

Summary

This Phase I study is to examine the systemic pharmacokinetics of RX0041-002 following acute, topical, intranasal administration to healthy male and female volunteers.

Phase:

Phase 1

Details

Lead Sponsor:

Pharmaceutical Project Solutions, Inc.